Wales has begun the rolled-out of a community pharmacy prescribing service as part of reforms agreed by the Welsh health minister last December.
Eluned Morgan approved wide-ranging changes following re-negotiation of the Community Pharmacy Contractual Framework with Community Pharmacy Wales, the
representative body for community pharmacies in Wales.
The roll out will allow appropriately trained community pharmacists to treat an extended range of conditions that currently require people to visit their GP.
Initially pharmacist prescribers will be able to prescribe medicines, including antibiotics for acute illnesses like urinary tract and upper respiratory tract infections, and also prescribe routine contraception.
The first of its kind in the UK, the service is being rolled out progressively across Wales, building on local schemes which are already in place.
What are the main effects and symptoms of Upper Respiratory Tract Infection (URTI) disease?
Click link Continue to read this post of this disease Pain? what are the side effects? Treatment!
Local pharmacists in England can now evaluate and provide treatment for patients with uncomplicated urinary tract infections (UTIs) in women under the age
of 65, without the need for a GP appointment.
The 'ByeByeUTI' scheme has been expanded across the country, following a successful pilot across North East and North Cumbria.
More than 30,000 women have been treated for uncomplicated urinary tract infections at local pharmacies since the pilot scheme was launched in July 2022 as part
of the NHS and government's primary care access recovery plan, according to NHS England.
The expansion of pharmacy services not only enhances patients' access to care but also frees up tens of thousands of GP appointments at the same time.
Dr Faisel Baig, Medical Director for Primary Care, NHS England North East and Yorkshire, said that the rollout of this service across the whole region will enable
many more women to receive "faster and easier" access to advice and treatment.
Wellness of your body depends a lot on your food habits, clothing, and lifestyle. But if there is a lapse in personal hygiene then it can cause the feeling of discomfort and uneasiness ,which is difficult to deal with. Lapse in personal hygiene may upshot either of following complaints especially in women: Bikini line rashes: caused due
PCOS is a serious disease of the female reproductive tract identified by male pattern baldness, hirsutism, sleep apnea and infertility. Unfortunately, there is no cure for it. However, some home remedies can help ease the symptoms.
The NHS plans to train hundreds of pharmacy staff, expanding their ability to provide advanced clinical services and assume wider roles in dispensing medicines.
With a targeted launch in September, up to 840 pharmacy technicians can join in the training programme. The online modules will cover consultation skills,
therapeutics, clinical decision-making, assessment skills, and service improvement.
"Community pharmacies are pivotal in local communities, and this novel training scheme empowers them to extend their service offerings to a wider patient base,"
said Health Minister Neil O'Brien. "Through our investment in the workforce, we're bolstering the implementation of the Pharmacy First initiative with £645 million,
ensuring patients have access to expert assistance for various common ailments, including urinary tract infections and earaches."
NHS said the training will offer flexibility to align with the working schedules and prior experience of community pharmacy technicians. It will combine independent
online e-course study, educational supervision, and clinical skills training. Facilitated workshops will concentrate on enhancing clinical assessment skills and
applying knowledge and skills through case studies, practice activities, and group discussions.
The menopause is a natural aging process, whereby a woman's oestrogen level drops thus disrupting periods until they eventually stop.
A woman is said to be in the menopause when her periods have stopped for 12 months. The age when this usually occurs is between 45-55 but symptoms can begin prior
to this. Symptoms vary and not all women experience them all.
They include hot flushes, vaginal dryness, joint and muscle pain, insomnia, reduced libido, urinary problems such as bladder weakness or Urinary Tract Infections
(UTIs), but this list is not exhaustive.
Up to a third of women declare that the menopause affects their quality of life. It is obvious that such physical changes can have an effect on ones well-being.
Women going through the menopause are at increased risk of developing depression, low self-esteem and problems with concentration (often called brain fog).
There are lots of misconceptions in the public and workplace around menopause as it is a little discussed topic. Did you know 45 per cent of women feel their
menopause symptoms have had a negative impact on their work and 47 per cent of women have said that they won't tell their employer if they need to take a day-off
from work because of menopausal symptoms?
So, with women making up nearly half of the UKs workforce, have you thought about what support your workplace offers for you? And if you are an employer, what could
you be doing to support your colleagues who need help during this time?
Northern Ireland's chief pharmaceutical officer paid a visit to a community pharmacy in Belfast on Monday (November 7) - marking the end of this year's Ask
Your Pharmacist week, an annual public awareness campaign launched by the National Pharmacy Association.
Cathy Harrison interacted with patients and staff in the pharmacy before recording a video to promote NI's 'Pharmacy First' service in which she described community
pharmacies as "one of the front doors to the health service" with over 500 outlets located across the country.
"In our community pharmacies you can always rely on friendly staff, medicines expertise, and walk-in access to face-to-face advice," she said.
First launched in Scotland, the NHS Pharmacy First service enables patients to have a consultation with a pharmacist for advice on minor ailments.
Ms Harrison also drew attention to community pharmacy's role in cancer awareness and helping people to quit smoking, as well as managing patients with urinary tract
infections, in addition to playing their part in delivering Covid-19 and flu vaccinations.
As part of a new blueprint for primary care, the government today (May 9) announced an investment of £645 million over two years to expand community pharmacy
services in England.
In a statement, NHS England said: "For the first time ever, patients who need prescription medication will be able to get it directly from a pharmacy, without a
GP appointment, for seven common conditions including earache, sore throat, or urinary tract infections."
Prime minister Rishi Sunak hopes that the measures will help end the "all-too stressful wait on the end of the phone for patients" by freeing up 15 million slots at
doctors' surgeries over the next two years.
"We will end the 8am rush and expand the services offered by pharmacies, meaning patients can get their medication quickly and easily," he said
Almost half a million women will no longer need to speak to a practice nurse or GP to access oral contraception and will instead be able to pop into their local
pharmacy for it, according to the government announcement.
Blood checks for people suffering from moderate risk of heart attack or stroke conducted in community pharmacies will more than double from 900,000 last year to
2.5 million next year.
NHS chief executive Amanda Pritchard said the "ambitious package" would help transform how care is provided within the health service "with pharmacies playing a
central role in managing the nation's health including providing lifesaving checks and medication for common conditions for the first time.
This Pharmacy First Common Ailments service will help patients seek treatment for seven common conditions directly from a pharmacy without the need
for a GP appointment or prescription.
Launching on 31 January next year although it is subject to IT being ready, the service will cover ailments including "sinusitis, sore throat, earache, infected
insect bites, impetigo, shingles, and uncomplicated urinary tract infections (UTIs)" in women.
People with symptoms of the above seven conditions will be supplied with a prescription-only treatment under a Patient Group Direction (PGD).
Patients seeking assistance at the pharmacy, whether walk-in or referred by NHS 111, GPs, or other sources, can receive consultations.
The new service includes self-referring patients plus referrals, and the Community Pharmacist Consultation Service (CPCS) will also be a part of it.
Acknowledging the ongoing challenges in delivering the required IT systems for the scheduled launch of the Pharmacy First service on January 31, NHS England
reported progress in fulfilling 'many' commitments outlined in its plan to enhance primary care access during a board meeting on Thursday.
However, it noted that the digital infrastructure supporting Pharmacy First, included in the £645 million fresh funding for community pharmacy, will require additional time for implementation.
"Delivery remains challenging due to changes needed in digital infrastructure, and we are working with suppliers to support January implementation," NHSE said.
"A public campaign is planned for 2024."
The Pharmacy First service allows pharmacists to supply prescription-only medicines for seven common health conditions (sinusitis, sore throat, earache, infected
insect bite, impetigo, shingles, and uncomplicated urinary tract infections in women), eliminating the need for a GP visit.
Meanwhile, NHSE is leveraging the widespread accessibility of pharmacies by expanding blood pressure monitoring and introducing direct prescribing of clinically
safe oral contraceptives-an initiative that has been well-received.
The Department of Health (DoH) Northern Ireland is reminding the public to think Pharmacy First this winter to stay well and reduce demands on other parts
of their health service.
Under this new advanced service, a local pharmacy can provide treatment and advice on a range of health conditions including common colds, stomach upsets, ear
aches, diarrhoea, head lice, mouth ulcers and thrush.
Pharmacies will also directly provide emergency contraception and advice and treatment for uncomplicated Urinary Tract Infections (UTI) for women aged 16 to 64
years without the need for a GP appointment, the department said.
Further the public are informed that 42 community pharmacies across the country will be providing a sore throat service this winter, involving advice, testing for
infection and treatment, if necessary.
YouGov polling commissioned by the Pharmaceutical Services Negotiating Committee (PSNC) has revealed that majority of the people responding to the poll said
that they would be concern by the pharmacy closure in their locality.
The results show the extent of the public backing for a Pharmacy First approach - PSNC has been arguing that a fully-funded service would be beneficial for pharmacies,
patients and the wider NHS.
The poll witnessed 1,774 adults' participation from England. It showed 68 per cent of people agree that they would find it easier to seek health advice for common
conditions, such as skin conditions or indigestion, at a community pharmacy rather than a GP surgery. Only 11 per cent disagreed that this would be easier.
While 75 per cent of people agree that they would like to see community pharmacies offering more healthcare services such as treating urinary tract infections or
sore throats. Only 6 per cent strongly disagreed with this.
When asked how important, if at all, are the services provided by community pharmacies to them, their family, or community, 78 per cent indicted this was very
important. Only 14 per cent said this wasn't important.
77 per cent said they would be very concerned if the pharmacy they use most often were to close permanently. Only 19 per cent said they would not be very concerned.
British pharmaceutical giant GSK said on Saturday (April 15) its oral antibiotic drug to treat uncomplicated urinary tract infections (uUTI) in female adults
and adolescents met the main goals in late-stage trials.
The drug, gepotidacin, in phase III trials, met its primary goals of being on a par or better than nitrofurantoin, the current standard of care for the treatment of
uUTIs, the company said.
GSK plans to submit results of the trials to the United States Food and Drug Administration for review later in the second quarter.
The drug, if approved, could become the first new type of antibiotic, which is critically important for countering drug-resistant infections, to treat uUTIs in 20
years, the company said.
"Gepotidacin, if approved, will offer a much-needed additional oral treatment option for patients at risk of treatment failure associated with resistance or
recurrence of uUTI," Chris Corsico, senior vice president of development at GSK, said.
As the Easter holiday draws near, pharmacies across Hampshire and the Isle of Wight are readying themselves to provide essential healthcare services
to residents.
Operational throughout Good Friday (March 29), Easter Sunday (March 31), and Easter Monday (April 1), these pharmacies stand poised to offer vital support to
those in need.
NHS England has raised awareness by releasing a comprehensive list of pharmacies scheduled to operate during the holiday period. Hampshire residents, including
those in Southampton and Portsmouth, can access detailed information about open pharmacies on the NHS England website, along with separate listings for the Isle
of Wight.
However, it's important to note that opening times may vary, prompting individuals to confirm details before visiting, as schedules are subject to change.
Beyond merely dispensing prescriptions, pharmacies are equipped to provide expert advice on minor illnesses and administer treatments for common conditions. This
includes addressing issues such as shingles, sore throats, infected insect bites, earaches, sinusitis, impetigo, and uncomplicated urinary tract infections
(UTI) under the Pharmacy First scheme.
The much-awaited Pharmacy First service has been launched in England, enabling patients to get treatment for seven common conditions from their community
pharmacists without needing to see a GP.
According to NHS England, a total of 10,265 community pharmacies, which is equivalent to more than nine in ten community pharmacies in the country, will be
offering the ground-breaking initiative.
The new scheme allows highly trained pharmacists to give advice and prescription-only medicines for minor ailments including sinusitis, sore throat, earache,
infected insect bite, impetigo, shingles, and uncomplicated urinary tract infections in women (under the age of 65).
With this major expansion of pharmacy services, the NHS is aiming to free up 10 million GP appointments a year while giving the public more choice in where and
how they access care.
More than 1000 pharmacies in England, including Boots stores, are now delivering the newly launched NHS Pharmacy First Service.
Launched on Wednesday (31 January), the new service enables pharmacists to provide advice and treatment, if appropriate, for seven common conditions, which
include sinusitis, sore throat, earache, infected insect bite, impetigo, shingles, or an uncomplicated urinary tract infection in women.
Instead of going to a GP surgery, patients can go to their community pharmacists to get treatment for these common conditions, without the need for an appointment.
Patients who may need additional support will be referred to a GP or another healthcare provider by the pharmacist.
Seb James, managing director of Boots UK and ROI, has described their launch of Pharmacy First service as "one of the most significant changes in how we can
serve our customers and patients in our 175-year history."
Pfizer on Thursday said a single dose of its new respiratory syncytial virus (RSV) vaccine Abrysvo maintained its ability to protect against the illness
through a second year of respiratory disease season.
The company said in a press release that the vaccine's efficacy against RSV-associated lower respiratory tract disease with three or more symptoms was 77.8 per cent
through season two, compared with efficacy of 88.9 per cent after the first RSV season, which led to the shot's US approval.
The data is from a late-stage trial of more than 37,000 participants being conducted in both the Northern and Southern hemispheres.
Cumulative efficacy over both seasons after around 16.4 months of disease surveillance was 81.5 per cent, Pfizer said.
The data is similar to the efficacy of GSK's rival RSV shot Arexvy over two seasons, which was released in June.
Almost all community pharmacies in the West Midlands and East Midlands have begun treating people for seven common conditions, as part of the newly launched
Pharmacy First scheme.
NHS England on Sunday (4 February) revealed that more than 95 per cent of community pharmacies in the West Midlands (1130) and over 97 per cent in the East
Midlands (840) have joined the ground-breaking initiative.
The scheme allows highly trained pharmacists to assess and treat patients for sinusitis, sore throat, earache, infected insect bite, impetigo, shingles, and
uncomplicated urinary tract infections in women (under the age of 65) without the need for an appointment or prescription.
With this major expansion of pharmacy services, the health service is aiming to free up 10 million GP appointments a year, while making it easier and more
convenient for people to access care.
Researchers from the London School of Hygiene & Tropical Medicine (LSHTM) have been tasked to evaluate the impact, safety and effectiveness of the
Pharmacy First service, which was launched across England in January 2024.
They have been awarded £2.4million by the National Institute for Health and Care Research (NIHR) to generate evidence on the new service that allows
pharmacies to provide advice and treatment for seven common conditions without the need for a GP appointment.
After consultation, if necessary, a community pharmacist can supply some prescription-only medicines to treat earache, sore throat, sinusitis, impetigo,
shingles, infected insect bites or uncomplicated urinary tract infections in women.
The LSHTM researcher team will be working together with experts at the UK Health Security Agency (UKHSA) and the Universities of Oxford, Manchester and
Nottingham on the project.
Dr Rebecca Glover, assistant professor in Antimicrobial Resistance at LSHTM, who will lead the three-year project, said they will evaluate "Pharmacy First's
impact on GPs and the wider NHS, pharmacy services and patients."